Xortx announces results of special meeting of shareholders

Calgary, alberta, oct. 27, 2023 (globe newswire) -- xortx therapeutics inc. ("xortx" or the “company”) (nasdaq: xrtx | tsxv: xrtx | frankfurt: anu), a late-stage clinical pharmaceutical company focused on developing innovative therapies to treat progressive kidney disease, announces the results of its special meeting of shareholders (the “meeting”) held earlier today.

XRTX Ratings Summary

XRTX Quant Ranking